Company: ARTL
Filing Date: 2025-09-03
Form Type: 8-K
Source: 0001640334-25-001617
Chunk: 2

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-09-03
Form: 8-K
Item: Item 8.01
Chunk 2
---
 The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise, except to the extent required by applicable securities laws.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               ARTELO BIOSCIENCES, INC.             
  Date: September 3, 2025      /s/ Gregory D. Gorgas                
                               Gregory D. Gorgas                    
                               President & Chief Executive Officer  

   3